溶在动脉样硬化中的新兴作用
Sylvia Vagena1,2, Giorgos Theocharous2, Alexios Theodorou1
1Department of Vascular Surgery, 1st Propaedeutic Department of Surgery, Hippocratio General Hospital, National and Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.
Medicina (Kaunas, Lithuania)
|December 31, 2025
概括
细胞衰老和炎症导致动脉样硬化. 像奎尔丁这样的老化疗法在减少斑块和改善血管健康方面表现有前途,补充了传统治疗方法.
科学领域:
- 心血管科学 心血管科学
- 衰老研究研究 衰老研究
- 细胞生物学 细胞生物学
背景情况:
- 动脉样硬化涉及细胞衰老和慢性炎症,导致血管损伤和斑块不稳定.
- 氧化应激,DNA损伤和炎症有助于衰老,增加动脉样硬化斑块中的炎症因素.
- 诸如Nrf2,ICAM-1和p38 MAPK/p16INK4A之类的关键通路与动脉样硬化发展有关.
研究的目的:
- 审查细胞衰老在动脉样硬化的发病过程中的作用.
- 突出针对衰老的干预措施作为常规治疗的辅助措施的潜力.
- 在实验性动脉样硬化模型中探索奎尔塞的老化潜力.
主要方法:
- 文献综述侧重于细胞衰老,炎症和动脉样硬化.
- 分析涉及疾病进展的关键分子通路.
- 在临床前模型中检查老化剂,特别是氨酸的证据.
主要成果:
- 细胞衰老加剧了动脉样硬化斑块的不稳定性,并损害了血管修复.
- 奎尔氨酸在模型中表现出老化活性,缓解巨细胞衰老,并减少斑块大小高达56%.
- 随着奎尔丁治疗,观察到改善的脂质样本.
结论:
- 针对衰老的干预措施,包括老化药物,为动脉样硬化治疗提供了一个有希望的补充策略.
- 奎尔赛丁显示出作为心血管健康的老化剂的显著潜力.
- 整合老化剂和营养药可能会改善与年龄相关的血管疾病的结果.
相关概念视频
Atherosclerosis I: Introduction
765
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
765
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291
Coronary Artery Disease II: Pathophysiology
336
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
Inflammation
61.4K
Overview
61.4K
Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
430
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
430

